Rafael Simó

Author PubWeight™ 70.93‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Exenatide twice daily versus glimepiride for prevention of glycaemic deterioration in patients with type 2 diabetes with metformin failure (EUREXA): an open-label, randomised controlled trial. Lancet 2012 2.79
2 Proinflammatory cytokines, insulin resistance, and insulin secretion in chronic hepatitis C patients: A case-control study. Diabetes Care 2006 1.99
3 Glucose abnormalities in patients with hepatitis C virus infection: Epidemiology and pathogenesis. Diabetes Care 2006 1.80
4 APOH is increased in the plasma and liver of type 2 diabetic patients with metabolic syndrome. Atherosclerosis 2009 1.56
5 Diabetes is the main factor accounting for the high ferritin levels detected in chronic hepatitis C virus infection. Diabetes Care 2004 1.55
6 [Factors influencing CRP levels in the diabetic population]. Med Clin (Barc) 2005 1.47
7 Lower zinc-alpha2-glycoprotein production by adipose tissue and liver in obese patients unrelated to insulin resistance. J Clin Endocrinol Metab 2009 1.46
8 Glucose abnormalities are an independent risk factor for nonresponse to antiviral treatment in chronic hepatitis C. Am J Gastroenterol 2007 1.44
9 Vascular endothelial growth factor and diabetic complications. Prog Retin Eye Res 2008 1.33
10 High prevalence of glucose abnormalities in patients with hepatitis C virus infection: a multivariate analysis considering the liver injury. Diabetes Care 2004 1.32
11 Fenofibrate - a potential systemic treatment for diabetic retinopathy? Am J Ophthalmol 2012 1.31
12 Iron deficiency in obese postmenopausal women. Obesity (Silver Spring) 2006 1.23
13 Lower somatostatin expression is an early event in diabetic retinopathy and is associated with retinal neurodegeneration. Diabetes Care 2007 1.20
14 Neurodegeneration: An early event of diabetic retinopathy. World J Diabetes 2010 1.08
15 Expression of erythropoietin and its receptor in the human retina: a comparative study of diabetic and nondiabetic subjects. Diabetes Care 2008 1.02
16 Study of the potential association of adipose tissue GLP-1 receptor with obesity and insulin resistance. Endocrinology 2011 1.00
17 Lowered cortistatin expression is an early event in the human diabetic retina and is associated with apoptosis and glial activation. Mol Vis 2008 1.00
18 Erythropoietin is expressed in the human retina and it is highly elevated in the vitreous fluid of patients with diabetic macular edema. Diabetes Care 2006 0.99
19 Beneficial effects of fenofibrate in retinal pigment epithelium by the modulation of stress and survival signaling under diabetic conditions. J Cell Physiol 2012 0.99
20 Phagocytic activity is impaired in type 2 diabetes mellitus and increases after metabolic improvement. PLoS One 2011 0.98
21 Proapoptotic and survival signaling in the neuroretina at early stages of diabetic retinopathy. Mol Vis 2013 0.97
22 CD4-CD8 and CD28 expression in T cells infiltrating the vitreous fluid in patients with proliferative diabetic retinopathy: a flow cytometric analysis. Arch Ophthalmol 2004 0.96
23 A nontargeted proteomic approach to the study of visceral and subcutaneous adipose tissue in human obesity. Mol Cell Endocrinol 2012 0.96
24 Arterial stiffness is increased in patients with type 1 diabetes without cardiovascular disease: a potential role of low-grade inflammation. Diabetes Care 2012 0.96
25 Strategies for blocking angiogenesis in diabetic retinopathy: from basic science to clinical practice. Expert Opin Investig Drugs 2007 0.94
26 Fenofibric acid reduces fibronectin and collagen type IV overexpression in human retinal pigment epithelial cells grown in conditions mimicking the diabetic milieu: functional implications in retinal permeability. Invest Ophthalmol Vis Sci 2011 0.93
27 Metabolic fingerprints of proliferative diabetic retinopathy: an 1H-NMR-based metabonomic approach using vitreous humor. Invest Ophthalmol Vis Sci 2010 0.92
28 Neuroprotection in diabetic retinopathy. Curr Diab Rep 2012 0.92
29 Diabetes is an independent risk factor for severe nocturnal hypoxemia in obese patients. A case-control study. PLoS One 2009 0.89
30 Usefulness of the vitreous fluid analysis in the translational research of diabetic retinopathy. Mediators Inflamm 2012 0.89
31 Somatostatin molecular variants in the vitreous fluid: a comparative study between diabetic patients with proliferative diabetic retinopathy and nondiabetic control subjects. Diabetes Care 2005 0.88
32 Erythropoietin produced by the retina: its role in physiology and diabetic retinopathy. Endocrine 2011 0.88
33 Encephalopathy associated with autoimmune thyroid disease in patients with Graves' disease: clinical manifestations, follow-up, and outcomes. BMC Neurol 2010 0.88
34 Topical administration of somatostatin prevents retinal neurodegeneration in experimental diabetes. Diabetes 2013 0.87
35 Serum markers of vascular inflammation in dyslipemia. Clin Chim Acta 2006 0.86
36 Lipoprotein(a) as a risk factor for cardiovascular mortality in type 2 diabetic patients: a 10-year follow-up study. Diabetes Care 2005 0.86
37 Insulin resistance is related to impaired lung function in morbidly obese women: a case-control study. Diabetes Metab Res Rev 2010 0.85
38 Gene expression of paired abdominal adipose AQP7 and liver AQP9 in patients with morbid obesity: relationship with glucose abnormalities. Metabolism 2009 0.85
39 Mice lacking PGC-1β in adipose tissues reveal a dissociation between mitochondrial dysfunction and insulin resistance. Mol Metab 2013 0.84
40 Serum myostatin levels in chronic heart failure. Rev Esp Cardiol 2010 0.84
41 Asymptomatic sleep-disordered breathing in premenopausal women awaiting bariatric surgery. Obes Surg 2009 0.84
42 Diabetes protects from prostate cancer by downregulating androgen receptor: new insights from LNCaP cells and PAC120 mouse model. PLoS One 2013 0.84
43 Update on cardiovascular safety of PPARgamma agonists and relevance to medicinal chemistry and clinical pharmacology. Curr Top Med Chem 2012 0.84
44 Variables involved in the discordance between HbA1c and fructosamine: the glycation gap revisited. PLoS One 2013 0.83
45 Iron overload in diabetic retinopathy: a cause or a consequence of impaired mechanisms? Exp Diabetes Res 2010 0.83
46 Diabetes is the main factor accounting for hypomagnesemia in obese subjects. PLoS One 2012 0.82
47 Effects of high glucose concentration on the barrier function and the expression of tight junction proteins in human retinal pigment epithelial cells. Exp Eye Res 2009 0.82
48 Glucose abnormalities in non-alcoholic fatty liver disease and chronic hepatitis C virus infection: the role of iron overload. Diabetes Metab Res Rev 2009 0.81
49 Differential effects of gemfibrozil and fenofibrate on reverse cholesterol transport from macrophages to feces in vivo. Biochim Biophys Acta 2010 0.81
50 New pathogenic candidates for diabetic macular edema detected by proteomic analysis. Diabetes Care 2010 0.81
51 Usefulness of homeostasis model assessment for identifying subjects at risk for hypoglycemia failure during the insulin hypoglycemia test. J Clin Endocrinol Metab 2004 0.81
52 Metformin: a new option in cancer treatment. Clin Transl Oncol 2011 0.80
53 High glucose concentration leads to differential expression of tight junction proteins in human retinal pigment epithelial cells. Endocrinol Nutr 2009 0.79
54 Effect of fenofibrate on retinal neurodegeneration in an experimental model of type 2 diabetes. Acta Diabetol 2014 0.79
55 Somatostatin and diabetic retinopathy: current concepts and new therapeutic perspectives. Endocrine 2014 0.78
56 Somatostatin replacement: a new strategy for treating diabetic retinopathy. Curr Med Chem 2013 0.78
57 Correlation between Retinal Vessel Calibre and Neurodegeneration in Patients with Type 2 Diabetes Mellitus in the European Consortium for the Early Treatment of Diabetic Retinopathy (EUROCONDOR). Ophthalmic Res 2016 0.78
58 Prevalence and risk factors accounting for true silent myocardial ischemia: a pilot case-control study comparing type 2 diabetic with non-diabetic control subjects. Cardiovasc Diabetol 2011 0.78
59 Measuring permeability in human retinal epithelial cells (ARPE-19): implications for the study of diabetic retinopathy. Methods Mol Biol 2011 0.78
60 Molecular Implications of the PPARs in the Diabetic Eye. PPAR Res 2013 0.78
61 Erythropoietin protects retinal pigment epithelial cells against the increase of permeability induced by diabetic conditions: essential role of JAK2/ PI3K signaling. Cell Signal 2011 0.78
62 Intravitreous leptin concentrations in patients with proliferative diabetic retinopathy. Retina 2004 0.78
63 Overexpression of hemopexin in the diabetic eye: a new pathogenic candidate for diabetic macular edema. Diabetes Care 2013 0.77
64 Lipopolysaccharide-binding protein and soluble CD14 in the vitreous fluid of patients with proliferative diabetic retinopathy. Retina 2010 0.77
65 Myostatin serum levels in heart failure. Eur J Heart Fail 2010 0.77
66 Effect of glycemic control on nocturnal arterial oxygen saturation: a case-control study in type 2 diabetic patients. J Diabetes 2014 0.77
67 Can augmentation index substitute aortic pulse wave velocity in the assessment of central arterial stiffness in type 1 diabetes? Acta Diabetol 2012 0.77
68 [Fenofibrate in the treatment of diabetic retinopathy]. Med Clin (Barc) 2008 0.77
69 Oleic acid increases hepatic sex hormone binding globulin production in men. Mol Nutr Food Res 2013 0.76
70 Effect of intensive insulin therapy on macular biometrics, plasma VEGF and its soluble receptor in newly diagnosed diabetic patients. Diabetes Metab Res Rev 2010 0.76
71 Identification of new pathogenic candidates for diabetic macular edema using fluorescence-based difference gel electrophoresis analysis. Diabetes Metab Res Rev 2013 0.76
72 Glycogen storage in the human retinal pigment epithelium: a comparative study of diabetic and non-diabetic donors. Acta Diabetol 2014 0.76
73 Testosterone induces cell proliferation and cell cycle gene overexpression in human visceral preadipocytes. Am J Physiol Cell Physiol 2013 0.76
74 V804M RET mutation and familial medullary thyroid carcinoma: report of a large family with expression of the disease only in the homozygous gene carriers. Surgery 2002 0.75
75 Biological variation of lipoprotein(a) in a diabetic population. Analysis of the causes and clinical implications. Clin Chem Lab Med 2003 0.75
76 Hepatocyte growth factor in the vitreous fluid of patients with proliferative diabetic retinopathy: its relationship with vascular endothelial growth factor and retinopathy activity. Diabetes Care 2004 0.75
77 Albumin excretion rate is not affected by asymptomatic urinary tract infection: a prospective study. Diabetes Care 2004 0.75
78 Non-islet-cell-induced hypoglycemia by "big-IGF-2" in a patient with retroperitoneal solitary fibrous tumor and a papillary thyroid carcinoma: An unusual association. Endocrinol Nutr 2013 0.75
79 Effects of depressive symptoms on clinical outcomes, inflammatory markers and quality of life after a significant weight loss in a bariatric surgery sample. Nutr Hosp 2017 0.75
80 [Role of myostatin in wasting syndrome associated with chronic diseases]. Med Clin (Barc) 2008 0.75
81 Normoalbuminuric type 1 diabetic patients with retinopathy have an impaired tubular response to desmopressin: its relationship with plasma endothelin-1. J Clin Endocrinol Metab 2009 0.75
82 Effects of hypolipidemic treatment on serum markers of vascular inflammation in dyslipidemic men. Med Sci Monit 2003 0.75
83 Development of a Normative Database for Multifocal Electroretinography in the Context of a Multicenter Clinical Trial. Ophthalmic Res 2017 0.75
84 New insights in the pathogenesis and treatment of diabetic retinopathy. Curr Med Chem 2013 0.75
85 Neurodegeneration as an early event in diabetic retinopathy. Endocrinol Nutr 2011 0.75